ZoomInfo Technologies Inc. GTM
Composite 42/100; the shares have moved about 81% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 7/100 — a strong mark against it.
Valuation ranks 84/100 — a strong point in its favour. Growth ranks 76/100 — a strong point in its favour.
Balance-sheet strength ranks 7/100 — a strong mark against it. Momentum ranks 25/100 — a strong mark against it. Quality ranks 27/100 — a moderate mark against it.
What the company does ZoomInfo Technologies provides go-to-market intelligence and engagement tools, including Copilot, Sales, Marketing, Operations, and Talent products, serving global enterprises and SMBs across industries like software, financial services, and healthcare.
Key financials ZoomInfo reports strong margins: gross 86.7%, operating 21.9%, net 10.1%. ROE is 8.1%, ROA 2.7%, and ROCE 4.3%. Revenue growth is modest at 1.5%, but EPS grew 23.2%. Debt/Equity is 1.07, with net debt/EBITDA at 4.21 and interest coverage of 5.30.
Stock health Quality and valuation scores are high (50.2 and 91.2), but momentum is weak (11.6) with 3m -45.84%, 6m -61.90%, and 12m -70.20% declines. The stock is -73.46% below its 52-week high and has an RSI(14) of 56.80.
Price vs fair value The stock trades at a **discount** of 150.00% to our fair-value estimate of 8.30 and a **discount** of 49.35% to the 12-month target of 4.96. - Trading at steep discounts to both fair value and analyst targets amid weak momentum (Sideravia Score). - Recent articles highlight partnerships and Q1 performance, but sentiment remains cautious (Simply Wall St., StockStory). - High valuation percentile (91.2) suggests limited upside unless execution improves.
Looking forward Forward P/E of 2.64 and EV/EBITDA of 6.77 indicate deep value, but weak momentum and high leverage (Debt/Equity 1.07) pose risks. Execution on growth initiatives and margin stability will be key to closing the valuation gap.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.